title: Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
authors.affiliation: Centre for Clinical Brain Sciences, University of Edinburgh, , Edinburgh, UK.
authors.forename: P
authors.initials: P
authors.lastname: Foley
authors.forename: A
authors.initials: A
authors.lastname: Lawler
authors.forename: S
authors.initials: S
authors.lastname: Chandran
authors.forename: G
authors.initials: G
authors.lastname: Mead
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy* / Q000209:etiology*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D015994:Incidence; D009103:Multiple Sclerosis / Q000523:psychology*; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors
keywords: Depression; Multiple Sclerosis; Quality of Life